STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-06-14
Here’s whether Bio-Techne Corp. (TECH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Caution.
🟡
Caution
Positives: above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+10.6%). Concerns: trading below the 200-day MA (long-term downtrend). Currently 25.2% off its 52-week high. Score: +0/7.
TECH is trading below its 200-day MA ($57.45) — a key warning sign the longer-term trend is under pressure. An RSI of 67.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +4.8% compares to +22.9% for SPY (trailed the market by 18.1%). The current 25.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $10,479 today
vs. S&P 500 (SPY) — same period trailed market by 18.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($57.45)
✓Above 50-day MA ($52.31)
✓RSI(14) neutral zone (30–70) — currently 67.7
✓Positive return (+4.8%)
!Within 10% of period high (−25.2%)
Period Range $54.00
$43.20$72.16
RSI (14) 67.7
0 · OversoldOverbought · 100
Key Metrics
Price$54.00
Period Return+4.8%
Period High$72.16
Period Low$43.20
Drawdown−25.2%
MA-50$52.31
MA-200$57.45
RSI (14)67.7
Avg Volume (30d)3.3M
vs. SPYtrailed by 18.1%
Return Rank#649 of 1246
Trend Signals
Price is below the 200-day moving average ($57.45)